Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Theratechnologies (TH.TO)

Theratechnologies (TH.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 280,880
  • Shares Outstanding, K 76,953
  • Annual Sales, $ 44,099 K
  • Annual Income, $ -4,529 K
  • 60-Month Beta 0.18
  • Price/Sales 3.58
  • Price/Cash Flow N/A
  • Price/Book 7.12
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.09
  • Most Recent Earnings -0.02 on 08/31/19
  • Next Earnings Date 02/20/20
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Drug Specialty & Generic

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 11/30/19
See More
  • Average Estimate -0.08
  • Number of Estimates 1
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year 0.00
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.38 +7.99%
on 01/09/20
4.31 -15.31%
on 12/31/19
+0.06 (+1.67%)
since 12/24/19
3-Month
3.38 +7.99%
on 01/09/20
5.40 -32.41%
on 11/11/19
-1.55 (-29.81%)
since 10/24/19
52-Week
3.38 +7.99%
on 01/09/20
9.47 -61.46%
on 03/01/19
-4.58 (-55.65%)
since 01/24/19

Most Recent Stories

More News
Theratechnologies Issues Preliminary Revenue Estimates for Fiscal Year 2019 and Revenue Guidance for Fiscal Year 2020

Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today provided preliminary revenue estimates for its recently completed fiscal year 2019...

THERF : 3.8000 (+4.68%)
TH.TO : 3.65 (-2.67%)
THTX : 2.78 (-2.46%)
Theratechnologies' CFO to Attend Piper Jaffray 31st Annual Healthcare Conference in New York City

Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that Philippe Dubuc, Senior Vice President and Chief Financial Officer will attend the 31 Annual Healthcare Conference starting...

THERF : 3.8000 (+4.68%)
TH.TO : 3.65 (-2.67%)
THTX : 2.78 (-2.46%)
Theratechnologies Starts Commercialization of New EGRIFTA SVáµ?á´¹ in the United States

Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, is pleased to announce that EGRIFTA SVáµ?á´¹ (2mg/vial) is now commercially available...

THERF : 3.8000 (+4.68%)
TH.TO : 3.65 (-2.67%)
THTX : 2.78 (-2.46%)
Theratechnologies' CFO to Attend Stifel Healthcare Conference in New York City

Theratechnologies Inc. (Theratechnologies) (TSX: TH), a commercial-stage biopharmaceutical company, is pleased to announce that Philippe Dubuc, Senior Vice President and Chief Financial Officer, will attend...

THERF : 3.8000 (+4.68%)
TH.TO : 3.65 (-2.67%)
THTX : 2.78 (-2.46%)
Trogarzo(R) Remains Effective Close to a Decade After Treatment Initiation

MONTREAL, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, is pleased to announce that data presented...

THERF : 3.8000 (+4.68%)
TH.TO : 3.65 (-2.67%)
THTX : 2.78 (-2.46%)
Theratechnologies Provides Details About R&D Day Webcast

Theratechnologies Inc. ("Theratechnologies" or the "Company") (NASDAQ: THTX) (TSX: TH), a commercial-stage pharmaceutical company addressing unmet medical needs for people with orphan medical conditions,...

THERF : 3.8000 (+4.68%)
THTX : 2.78 (-2.46%)
TH.TO : 3.65 (-2.67%)
REMINDER - Tesamorelin Study Results on NAFLD Published in Lancet HIV

Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX) is pleased to announce that results from a recent trial conducted at the Massachusetts General Hospital and the National Institute of...

THERF : 3.8000 (+4.68%)
TH.TO : 3.65 (-2.67%)
THTX : 2.78 (-2.46%)
Tesamorelin Study Results on NAFLD Published in Lancet HIV

Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX) is pleased to announce that results from a recent trial conducted at the Massachusetts General Hospital and the National Institute of...

THERF : 3.8000 (+4.68%)
TH.TO : 3.65 (-2.67%)
THTX : 2.78 (-2.46%)
Canadian Commercial-Stage Biopharmaceutical Company Theratechnologies Announces NASDAQ Listing

Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX: TH), a commercial-stage biopharmaceutical company addressing unmet medical needs for people with orphan medical conditions, including...

THERF : 3.8000 (+4.68%)
TH.TO : 3.65 (-2.67%)
THTX : 2.78 (-2.46%)
Theratechnologies Announces Financial Results for the Third Quarter of 2019

Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the third quarter ended August 31, 2019.

THERF : 3.8000 (+4.68%)
TH.TO : 3.65 (-2.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

2nd Resistance Point 3.88
1st Resistance Point 3.77
Last Price 3.65
1st Support Level 3.58
2nd Support Level 3.50

See More

52-Week High 9.47
Fibonacci 61.8% 7.14
Fibonacci 50% 6.43
Fibonacci 38.2% 5.71
Last Price 3.65
52-Week Low 3.38

See More

Business Summary

Theratechnologies Inc is a specialty pharmaceutical company which addresses unmet medical needs of HIV patients. The firm mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar